The COVALAC Study: The Impact of COVID-19 Vaccination During Lactation on SARS-CoV-2-Specific Antibodies in Human Milk—A Prospective Cohort Study
- 27 March 2026
- journal article
- Published by SAGE Publications in Journal of Human Lactation
Abstract
Background: The COVID-19-pandemic prompted global vaccination campaigns, raising important questions about vaccine-induced immune responses in lactating women and the transfer of SARS-CoV-2-specific antibodies through human milk. This study investigated the presence of SARS-CoV-2-specific IgA and IgG antibodies in breastmilk for up to 6 months following COVID-19 vaccination and booster doses with either mRNA or adenoviral vector (AVV) vaccines. Method: The COVALAC-study was a prospective cohort study conducted in Belgium. Women were recruited between February and March 2021, followed for 180 days post-vaccination and 28 days post-booster. Breastmilk samples were collected at multiple timepoints and analyzed for IgA and IgG antibodies. Participants received either mRNA (BNT162b2, mRNA-127) or AVV (ChAdOx1 nCoV-19) vaccines. Antibody concentrations were measured using an in-house immunoassay, and analyses compared responses between vaccine types. Results: Of the 115 participants, 40% received BNT162b2, 4.3% mRNA-1273, and 55.7% ChAdOx1-S as their primary vaccination. Of these, 31 participants received an mRNA booster (11 homologous, 20 heterologous boosters). IgA and IgG antibody levels were monitored pre- and post-vaccination, showing a stronger antibody response after mRNA vaccination compared to AVV, after roughly 14 days (IgA receptor binding domain [RBD] 1.13 BAU/mil; 0.61–1.67; IgG RBD 2.56 BAU/mil; 0.76–4.71, up to 1 month, for most antibodies. Both homologous and heterologous boosters further increased antibody titers (IgA RBD 0,85 BAU/ml; 1.09–1.72). Conclusion: COVID-19 vaccination during lactating induces SARS-CoV-2 specific IgA and IgG antibodies in human milk. Antibody levels were higher following mRNA vaccination compared to AVV vaccination, with booster doses enhancing these levels further.Keywords
Funding Information
- The Mustela Foundation
- Fabian Thylmann
This publication has 21 references indexed in Scilit:
- The importance of COVID-19 vaccination during lactationInfectious Diseases Now, 2023
- Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protectioniScience, 2023
- COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant womenAmerican Journal of Obstetrics and Gynecology, 2022
- Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccineAmerican Journal of Obstetrics and Gynecology, 2021
- Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of actionnpj Vaccines, 2021
- Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating WomenJAMA, 2021
- International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samplesVaccine, 2021
- COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyadsmedRxiv, 2021
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020